Journal of Cardiothoracic and Vascular Anesthesia
Volume 23, Issue 5 , Pages 625-632 , October 2009

Esmolol Reduces Perioperative Ischemia in Cardiac Surgery: A Meta-analysis of Randomized Controlled Studies

References 

  1. ACC/AHA. 2007 guidelines on perioperative cardiovascular evaluation and care for non cardiac surgery: A report of American College of Cardiology/American Heart Association Task Force on practice guidelines. Anesth Analg. 2008;1063:685–712
  2. McGory ML, Maggard MA, Ko CY. A meta-analysis of perioperative beta-blockade: What is the actual risk reduction?. Surgery. 2005;138:171–179
  3. Weisbauer F, Schagler O, Domanovits H, et al. Perioperative beta-blockers for preventing surgery related mortality and morbidity: A systematic review and meta-analysis. Anesth Analg. 2007;104:27–41
  4. Crystal E, Garfinkle MS, Connolly SS, et al. Interventions for preventing postoperative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev. 2004;18:CD 003611
  5. Ferguson TB, Coombs LP, Peterson ED. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA. 2002;287:2221–2227
  6. Fita G, Gomar C, Rovira I. Esmolol in anaesthesiology: Pharmacology and indications. Rev Esp Anestesiol Reanim. 1999;46:401–414
  7. Ravussin P. Characteristics and clinical use of esmolol. Minerva Anestesiol. 1992;58(suppl 1):77–79
  8. Cork R, Kramer TH, Dreischmeier B, et al. The effect of esmolol given during cardiopulmonary bypass. Anesth Analg. 1995;80:28–40
  9. Boldt J, Brosch C, Lehmann A, et al. The prophylactic use of the beta-blocker esmolol in combination with phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients. Anesth Analg. 2004;99:1009–1017
  10. Scorsin M, Mebazaa A, Al Attar N, et al. Efficacy of esmolol as a myocardial protective agent during continuous retrograde blood cardioplegia. J Cardiothorac Vasc Surg. 2003;125:1022–1029
  11. Deng YK, Wei F, Li ZL, et al. Esmolol protects the myocardium and facilitates intracardiac operation with a beating heart. Circulation. 2002;66:715–717
  12. Kurian SM, Evans R, Fernandes NO, et al. The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery. Anaesthesia. 2001;56:1163–1168
  13. Mehlhorn U, Fattah M, Kuhn-Regnier F, et al. Impact of myocardial protection during coronary bypass surgery on patient outcome. Cardiovasc Surg. 2001;9:482–486
  14. Mooss AN, Wurdeman RL, Mohiuddin SY, et al. Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery. Am Heart J. 2000;140:176–180
  15. Mehlhorn U, Blochb W, Krahwinkelb A, et al. Activation of myocardial constitutive nitric oxide synthase during coronary artery surgery. Eur J Cardiothorac Surg. 2007;17:305–311
  16. Mehlhorn U, Sauer H, Kuhn-Regnier F, et al. Myocardial β-blockade as an alternative to cardioplegic arrest during coronary artery surgery. Cardiovasc Surg. 1999;7:549–557
  17. Kuhn-Regnier F, Natour E, Dheind S, et al. Beta-blockade versus Buckberg blood-cardioplegia in coronary bypass operation. Eur J Cardiothorac Surg. 1999;15:67–74
  18. Newsome LR, Roth JV, Hug CC, et al. Esmolol attenuates hernodynamic responses during fentanyl-pancuronium anesthesia for aortocoronary bypass surgery. Anesth Analg. 1986;65:451–456
  19. Arar C, Colak A, Alagol A, et al. The use of esmolol and magnesium to prevent haemodynamic responses to extubation after coronary artery grafting. Eur J Anesthesiol. 2007;24:826–831
  20. Balcetyte-Harris N, Tamis JE, Homel P, et al. Randomized study of early intravenous esmolol versus oral beta-blockers in preventing post-CABG atrial fibrillation in high risk patients identified by signal-averaged ECG: Results of a pilot study. Ann Noninvasive Electrocardiol. 2002;7:86–91
  21. Maniar PB, Balcetyte-Harris N, Tamis JE, et al. Intravenous versus oral beta-blockers for prevention of post-CABG atrial fibrillation in high-risk patients identified by signal-averaged ECG: lessons of a pilot study. Cardiac Electrophysiol Rev. 2003;7:158–161
  22. Hilleman DE, Reyes AP, Mooss AN, et al. Esmolol versus diltiazem in atrial fibrillation following coronary bypass graft surgery. Curr Med Res Opin. 2003;19:376–382
  23. Rinne T, Hairmonen A, Kaukinen S. Esmolol cardioplegia in unstable coronary revascularisation patients. Acta Anesthesiol Scand. 2000;44:727–732
  24. Chahuan S, Saxena N, Rao BH, et al. A comparison of esmolol and diltiazem for heart rate control during coronary revascularisation on beating heart. Indian J Med Res. 1999;110:174–177
  25. Hekamt K, Clemens RM, Mehlhorn U, et al. Emergency coronary artery surgery after failed PTCA: Myocardial protection with continuous coronary perfusion of beta-blocker enriched blood. Thorac Cardiovasc Surg. 1998;46:333–338
  26. Cork RC, Azari DM, McQueen KAK, et al. Effect of esmolol given during cardiopulmonary bypass on fractional area of contraction from transesophageal echocardiography. Anesth Analg. 1995;81:219–224
  27. Neustein SM, Bronheim DS, Lasker S, et al. Esmolol and intraoperative myocardial ischemia: A double-blind study. J Cardiothorac Vasc Anesth. 1994;8:273–277
  28. Boylan JF, O'Leary J, Weisel RD, et al. A comparison of esmolol, diltiazem, nifedipine and nitroprusside therapy of post-CABG hypertension. Can J Anesth. 1990;37:s156
  29. Kling D, Boldt J, Zickmann B, et al. The hemodynamic effect of treatment with beta-receptor blockers during coronary surgery (A comparison between acebutolol and esmolol). Anaesthesist. 1990;39:264–268
  30. Harrison L, Ralley FE, Wynands E, et al. The role of an ultra-short adrenergic blocker (esmolol) in patients undergoing coronary artery bypass surgery. Anesthesiology. 1987;66:413–418
  31. Girard D, Shulman BJ, Thys DM, et al. The safety and efficacy of esmolol during myocardial revascularisation. Anesthesiology. 1986;65:157–164
  32. De Brujin NP, Croughwell N, Reves JG. Hemodynamic effects of esmolol in chronically beta-blocked patients undergoing aortocoronary bypass surgery. Anesth Analg. 1987;66:137–141
  33. Tempe DK, Mulchandani P, Tandon SM, et al. Control of tachycardia and hypertension following coronary artery bypass graft surgery: Efficacy and haemodynamic effects of esmolol. Indian Heart J. 1999;51:294–300
  34. O'Dwyer JP, Yorukoglu D, Harris MNE. The use of esmolol to attenuate the haemodynamic response when extubating patients following cardiac surgery—A double blind controlled study. Eur Heart J. 1993;14:701–704
  35. Gray RJ, Bateman TM, Czer LSC, et al. Use of esmolol in hypertension after cardiac surgery. Am J Cardiol. 1985;56:49F–56F
  36. Reves JG, Croughwell ND, Hawkins E, et al. Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. J Cardiovasc Surg. 1990;100:221–227
  37. Gray RJ, Bateman TM, Czer LSC, et al. Comparison of esmolol and nitroprusside for acute post-cardiac surgery hypertension. Am J Cardiol. 1987;59:887–891
  38. Higgins JPT, Green S. The Cochrane Handbook for Systematic Reviews of Interventions 4.2.5. http://www.cochrane.org/resources/handbook/hbook.htmAccessed October 10, 2005
  39. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement (Quality of reporting of meta-analyses). Lancet. 1999;354:1896–1900
  40. Biondi-Zoccai GG, Lotrionte M, Abbate A, et al. Compliance with QUOROM and quality of reporting of overlapping metaanalysis on the role of acetylcysteine in the prevention of contrast associated nephropathy: Case study. BMJ. 2006;332:202–209
  41. Killingsworth CR, Wei CC, Dell'Italia LJ, et al. Shorting-acting beta-adrenergic antagonist esmolol given at reperfusion improves survival after prolonged ventricular fibrillation. Circulation. 2004;109:2469–2474
  42. Rosenfeld DM, Trentman TL, Hentz JG, et al. Patients understanding of the importance of the beta-blocker use in the perioperative period. J Cardiothorac Vasc Anesth. 2007;21:325–329
  43. A report of the American College of Cardiology/American Heart Association ACC/AHA guidelines and indications for coronary artery bypass graft surgery (Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Coronary Artery Bypass Graft Surgery)). Circulation. 1991;83:1125–1173
  44. Landoni G, Pappalardo F, Calabrò MG, et al. Myocardial necrosis biomarkers after different cardiac surgical operations. Minerva Anestesiol. 2007;73:49–56
  45. Beattie WS, Wijeysundera DN, Karkouti K, et al. Does tight heart rate control improve beta-blocker efficacy? (An update analysis of the noncardiac surgical randomized trials). Anesth Analg. 2008;106:1025–1030
  46. Opie LH. Myocardial infarct size (Part 1. Basic considerations). Am Heart J. 1980;100:355–372
  47. Becker LC, Fortuin NJ, Pitt B. Effect of ischemia and antianginal drugs on the distribution of radioactive microspheres in the canine left ventricle. Circ Res. 1971;28:263–269
  48. Frishman WH, Chang CM. Beta-adrenergic blockade in the prevention of myocardial infarction: A new theory. J Hypertens Suppl. 1991;9:531–534
  49. Heringlake M, Bahlmann L, Misfeld M, et al. High myocardial concentration is associated with poor myocardial function prior to cardiopulmonary bypass. Minerva Anestesiol. 2005;71:775–783
  50. Feringa HH, Bax JJ, Boersma E, et al. High dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients. Circulation. 2006;114(suppl):1344–1349
  51. POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing noncardiac surgery (POISE trial): A randomised controlled trial. Lancet. 2008;371:1839–1847

PII: S1053-0770(09)00004-4

doi: 10.1053/j.jvca.2009.01.003

Journal of Cardiothoracic and Vascular Anesthesia
Volume 23, Issue 5 , Pages 625-632 , October 2009

Article Tools

* Image Usage & Resolution